Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomesEmilia Bober, Ian Yeung, Narciss Okhravi et al.|Eye|2023Cited by 6
Predictive Factors for Magnetic Resonance Imaging Changes Suggestive of Demyelination in Adult Patients with Uveitis Scanned Prior to Commencing Adalimumab TherapyPriyanka Sanghi, Mark Westcott, Joshua Luis et al.|Ocular Immunology and Inflammation|2022Cited by 4
Oral immunosuppression practice for inflammatory eye disease: A one-year analysis of prescriptions at Moorfields Eye HospitalTasanee Braithwaite, Narciss Okhravi, Jason Delisser et al.|Unknown|2019Cited by 0
MRI Screening for Adalimumab Therapy in UveitisJoshua Luis, Mark Westcott, Priyanka Sanghi et al.|Investigative Ophthalmology & Visual Science|2019Cited by 0